Searched for
LEVETIRACETAM INJECTION
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some not
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...28 Mar, 2026, 12.24 PM IST
- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...01 Feb, 2026, 05.13 PM IST
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...08 Sep, 2025, 02.45 PM IST
- Dr Reddy's, Lupin recall products in US due to labelling, manufacturing errors: USFDADr. Reddy's Laboratories and Lupin are recalling products in the US due to labeling and manufacturing issues. Dr. Reddy's is recalling an a...22 Apr, 2025, 05.46 PM IST
- Dr Reddy’s shares in focus after recall of mislabelled Levetiracetam injection in USThe potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, respiratory depression...17 Mar, 2025, 08.17 AM IST
- Stocks in news: Dr Reddy’s, Shilpa Medicare, Voltas, TCS, Tata MotorsDomestic markets closed slightly lower last week amid mixed global cues. Shares of Dr Reddy’s, Shilpa Medicare, and Tata Motors will be in ...17 Mar, 2025, 06.19 AM IST
- Dr. Reddy’s recalls mislabelled Levetiracetam injection in the US; patients likely to experience 'adverse' eventsDr. Reddy’s Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which could result in ...13 Mar, 2025, 05.36 PM IST
- Mapping the market: IT stocks shine on weak rupee; select smallcaps soarThe market behaviour on Monday, which was similar to what we saw many times last week, simply meant equity investors on Dalal Street have n...09 Jan, 2017, 04.22 PM IST
- Aurobindo Pharma surges 5% on getting USFDA approval for LevetiracetamAurobindo's Levetiracetam in Sodium Chloride Injection is a generic equivalent of HQ Specialty Pharma Corp's Levetiracetam in Sodium Chlori...09 Jan, 2017, 10.27 AM IST
- Mapping the market: Dalal Street had a dull day; here is who won and who lostBesides money policy expectations, what probably kept investors on tenterhooks was the Finance Minister’s meeting with the chiefs of PSBs d...06 Jun, 2016, 05.09 PM IST
- Jubilant Lifesciences surges as USFDA gives final nod for epilepsy drugShares of Jubilant Lifesciences surged 6 per cent in trade on Monday after the firm received final approval for its generic drug from USFDA.06 Jun, 2016, 04.11 PM IST
- Sensex snaps 3-day winning streak to end lower ahead of RBI policy meetThe lack of domestic triggers and an opportunity for re-allocation of portfolios post the end of the March quarter earnings also weighed on...06 Jun, 2016, 03.56 PM IST
- Fifteen stocks in focus in Monday morning tradeThe Indian market is expected to open flat. Here is a list of top fifteen stocks that are likely to be in focus today.06 Jun, 2016, 07.56 AM IST
- Aurobindo gets USFDA nod for epilepsy, arthritis drugsLevetiracetam injection is used for treatment of partial onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, a...02 Feb, 2016, 12.53 PM IST
- Shakers on D-Street: TTK Prestige, Aurobindo, Sun PharmaICICI Securities has initiated coverage of TTK Prestige with an ‘Add’ rating and a price target of Rs 3,900.20 Dec, 2013, 04.16 AM IST
- Sun Pharma receives USFDA nod for anti-anxiety drugSun Pharmaceutical Industries today said that it has received the US Food and Drug Administration's nod to market a generic version of alpr...18 Jun, 2010, 02.13 PM IST
- Sun Pharma gets US regulator's nod for epilepsy drugDrug maker Sun Pharmaceutical Industries on Thursday said it has received the US health regulator's nod for marketing a generic version of ...17 Jun, 2010, 02.22 PM IST
Load More
